HomeBUSINESS
BUSINESS

Maruho Exec Requests Discussions on Proper Use of Heparinoid Agents Based on “Appropriate Data,” Calls for Detailed Analysis of NDB
(Nov.17.2017)

The Central Social Insurance Medical Council (Chuikyo) should discuss the use of heparinoid agents such as Maruho’s Hirudoid (heparinoid) based on appropriate data on actual prescribing, Masahiro Takeda, a director of the board at Maruho, told Jiho. He also asked the health ministry to provide the results of a detailed analysis of the national insurance claim database dubbed NDB ...
(LOG IN FOR FULL STORY)

News Calendar